Tango Therapeutics

Youtube Subscribe

Open: 11.94 Close: 11.38 Change: -0.56

Stop waiting time to find out about Tango Therapeutics Company Inc: Our AI summarizes all info about it.

Are looking for the most relevant information about Tango Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Tango Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Tango Therapeutics are: Tango, Therapeutics, company, cancer, drug, rival, Inc, and the most common words in the summary are: ataxia, news, scientific, state, united, therapeutic, friedreichs, . One of the sentences in the summary was: Tango Therapeutics, Inc.has a strategic collaboration with Gilead Sciences, Inc. Other …

Concept Map

Semantic Network

Stock Summary

Tango Therapeutics, Inc. discovers and develops drugs for the treatment of cancer. Lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5. Company also develops TNG.

Today's Summary

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. The market capitalization of a company is the value of a publicly listed company. Boston-based rival Tango Therapeutics Inc., a rival to Mirati, also saw its shares end sharply higher Thursday. Shares of Tango, which is developing similar cancer drug candidates. Tango Therapeutics, Inc.has a strategic collaboration with Gilead Sciences, Inc. The first patient has been dosed in the phase 1/2 trial evaluating TNG260 in combination with pembrolizumab in patients with STK11-mutant cancers.

Today's News

Tango Therapeutics is a biotechnology company dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. The market capitalization of a company is the value of a publicly listed company. Boston-based rival Tango Therapeutics Inc., a rival to Mirati, also saw its shares end sharply higher Thursday. Shares of Tango, which is developing similar cancer drug candidates. Tango Therapeutics, Inc.has a strategic collaboration with Gilead Sciences, Inc. The first patient has been dosed in the phase 1/2 trial evaluating TNG260 in combination with pembrolizumab in patients with STK11-mutant cancers.

Stock Profile

"Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops TNG462, an oral small molecule methylthioadenosine-cooperative inhibitor for the treatment for cancers with methylthioadenosine phosphorylase deletions; TNG260, a co-repressor of repressor element-1 silencing transcription -selective inhibitor; TNG348, an ubiquitin-specific protease 1 inhibitor to treat patients with BRCA1 or BRCA2-mutant cancers; and Target 3 for STK11-mutant cancers. Tango Therapeutics, Inc. has a strategic collaboration with Gilead Sciences, Inc. for the discovery, development, and commercialization of a pipeline of therapies for patients with cancer. The company was founded in 2017 and is headquartered in Boston, Massachusetts."

Keywords

The game is changing. There is a new strategy to evaluate Tango Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Tango Therapeutics are: Tango, Therapeutics, company, cancer, drug, rival, Inc, and the most common words in the summary are: ataxia, news, scientific, state, united, therapeutic, friedreichs, . One of the sentences in the summary was: Tango Therapeutics, Inc.has a strategic collaboration with Gilead Sciences, Inc. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #ataxia #news #scientific #state #united #therapeutic #friedreichs.

Read more →

Youtube Subscribe

---